AGNPD
Algernon Health Inc.
기간
0.29 USD
최근 종가 · 사전계산값
- PER (TTM)
- -
- PER (Forward)
- -
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 1.01
- 시가총액
- 1.56M
- 배당수익률
- -
- 베타
- -
- 1개월 수익률
- -18.43%
- 3개월 수익률
- -51.77%
- 6개월 수익률
- -39.94%
- 1년 수익률
- -44.68%
- 2년 수익률
- -
- 5일 평균거래량
- 880
- 60일 평균거래량
- 1121
- 1년 평균거래량
- 1223
- 5d/60d 거래량 비율
- 0.78×
- 60d/1y 거래량 비율
- 0.92×
- 변동성(60일, 연환산)
- 181.49%
- BB 스퀴즈 스코어
- 1.20
- SMA50 비율
- 0.83
- SMA200 비율
- 0.58
- RSI (14)
- 45
- 20일 수렴도
- 0.13
- 52주 최고
- 0.85
- 52주 최저
- 0.23
- 고점 대비
- -66.16%
- 저점 대비
- 25.07%
펀더멘털 갱신: 2026-05-10T07:33:06+00:00 · 시세 갱신: 2026-05-10T06:07:52+00:00
회사 정보
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.